AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 3 cents for fourth-quarter fiscal 2025, narrower than the ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q4 2025 earnings on Jul 15, 2025. The consensus estimate for Q4 2025 ...

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

(ANGO) on Tuesday reported a loss of $6.1 million in its fiscal fourth quarter. The Latham, New York-based company said it had a loss of ...

But AngioDynamics, the Latham-based medical device manufacturer, is transforming itself during the pandemic, even as its earnings have temporarily suffered as elective medical procedures have been ...

QUEENSBURY -- Queensbury-based medical device manufacturer AngioDynamics Inc. said Tuesday afternoon it expects to be in its new headquarters building in Latham by early spring. The company ...

AngioDynamics, Inc. ( NASDAQ: ANGO) Q4 2025 Earnings Conference Call July 15, 2025 8:00 AM ET James C. Clemmer - CEO, President & Director Stephen A. Trowbridge - Executive VP & CFO ...